Taurine and inflammatory diseases.
Taurine and inflammatory diseases.
复制标题
DOI:
10.1007/s00726-012-1361-4
复制
发表时间:
2014-01
期刊:
影响因子:
3.5
通讯作者:
Kontny E
中科院分区:
文献类型:
--
作者:
Marcinkiewicz J;Kontny E
Taurine (2-aminoethanesulfonic acid) is the most abundant free amino acid in humans and plays an important role in several essential biological processes such as bile acid conjugation, maintenance of calcium homeostasis, osmoregulation and membrane stabilization. Moreover, attenuation of apoptosis and its antioxidant activity seem to be crucial for the cytoprotective effects of taurine. Although these properties are not tissue specific, taurine reaches particularly high concentrations in tissues exposed to elevated levels of oxidants (e.g., inflammatory cells). It suggests that taurine may play an important role in inflammation associated with oxidative stress. Indeed, at the site of inflammation, taurine is known to react with and detoxify hypochlorous acid generated by the neutrophil myeloperoxidase (MPO)–halide system. This reaction results in the formation of less toxic taurine chloramine (TauCl). Both haloamines, TauCl and taurine bromamine (TauBr), the product of taurine reaction with hypobromous acid (HOBr), exert antimicrobial and anti-inflammatory properties. In contrast to a well-documented regulatory role of taurine and taurine haloamines (TauCl, TauBr) in acute inflammation, their role in the pathogenesis of inflammatory diseases is not clear. This review summarizes our current knowledge concerning the role of taurine, TauCl and TauBr in the pathogenesis of inflammatory diseases initiated or propagated by MPO-derived oxidants. The aim of this paper is to show links between inflammation, neutrophils, MPO, oxidative stress and taurine. We will discuss the possible contribution of taurine and taurine haloamines to the pathogenesis of inflammatory diseases, especially in the best studied example of rheumatoid arthritis.
登录
查看更多内容
影响因子:
4.4
作者:
Barua, M;Liu, Y;Quinn, MR
通讯作者:
Quinn, MR
DOI:
10.1016/0162-3109(96)00113-0
发表时间:
1996-09-01
期刊:
IMMUNOPHARMACOLOGY
影响因子:
--
作者:
Kim, C;Park, E;SchullerLevis, G
通讯作者:
SchullerLevis, G
影响因子:
5.6
作者:
Kim, Chaekyun;Jang, Jin Sun;Cha, Young-Nam
通讯作者:
Cha, Young-Nam
影响因子:
4.9
作者:
Kim, Kyoung Soo;Park, Eun Kyung;Ju, Seung Min;Jung, Hye-Sook;Bang, Jun Soo;Kim, Chaekyun;Lee, Yeon-Ah;Hong, Seung-Jae;Lee, Sang-Hoon;Yang, Hyung-In;Yoo, Myung Chul
通讯作者:
Yoo, Myung Chul
DOI:
10.1097/01.mco.0000247469.26414.55
发表时间:
2006-11-01
影响因子:
3.1
作者:
Bouckenooghe, Thomas;Remacle, Claude;Reusens, Brigitte
通讯作者:
Reusens, Brigitte